Clinical Trial Update: A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline. [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of Ladarixin in new-onset Type 1 diabetes patients with preserved beta-cell function was terminated; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Ladarixin (ladarixin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: New-onset Type 1 Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2025-05-14